%0 Journal Article %A CA Smith %A M Bythell %A C Rounding %A ES Draper %T Birth prevalence of exomphalos, associated anomalies and outcomes in England & Wales: 1997–2007 %D 2010 %R 10.1136/adc.2010.192310.4.4 %J Archives of Disease in Childhood - Fetal and Neonatal Edition %P Fa10-Fa10 %V 95 %N Suppl 1 %X Background The majority of cases of exomphalos are diagnosed during the antenatal period. Up-to-date information about associated anomalies and outcomes are required to facilitate counselling and management. Aim To examine the trend in the birth prevalence of exomphalos in England & Wales (E&W) from 1997 to 2007. To describe associated anomalies, outcomes and survival to 1 year. Method Data for all cases with exomphalos notified to eight Congenital Anomaly Registers across E&W, between 1997 and 2007, was analysed by year of birth. Results 1191 cases of exomphalos were reported over the 11-year period. During this time the birth prevalence of exomphalos showed a significant increasing trend from 2.9 (95% CI 2.5 to 3.3) to 4.3 (3.9 to 4.7) per 10 000 births (X2 test for trend, p<0.0001). 564 (47.4%) cases were electively terminated. 417 (35%) of all infants, were live born and 307 (25.8%) survived to 1 year of age. Of the 341 infants with isolated exomphalos, 197 (57.8%) were live born and 149 (43.7%) were reported to be alive at 1 year of age. Chromosomal anomalies were reported in 354 (29.7%) cases, two thirds of these cases were trisomy 18. The other most commonly reported associated anomalies were musculo-skeletal (31.9%), cardiac (20.7%) and neurological (13.4%). Conclusion There was a significant increase in the birth prevalence of exomphalos in E&W from 1997 to 2007. Approximately half of all exomphalos cases were terminated and a further quarter survived to 1 year of age. However, survival in isolated exomphalos cases was significantly higher than in cases with associated anomalies (43.7% vs 18.6%). %U https://fn.bmj.com/content/fetalneonatal/95/Suppl_1/Fa10.2.full.pdf